Literature DB >> 9291852

HLA DRB1* typing and cartilage oligomeric matrix protein (COMP) as predictors of joint destruction in recent-onset rheumatoid arthritis.

F A Wollheim1, K B Eberhardt, U Johnson, T Saxne.   

Abstract

The carriage of a characteristic sequence of amino acids at position 67-72 in the third hypervariable region of the HLA DRB1 chain has been linked to susceptibility to rheumatoid arthritis (RA). Whether this epitope is also a predictor of more severe disease remains controversial. Cartilage oligomeric matrix protein (COMP) is a protein, the serum levels of which have been found to correlate with large joint destructive disease in previous work. In this paper, we compare DRB1* typing and serum COMP levels in a prospectively observed group of RA patients with or without early hip joint destruction. The COMP levels at study inclusion, median 11 months from onset of symptoms, were significantly higher in the patients with early hip joint destruction compared to the patients in the more benign group. There was no difference in the number of disease susceptibility-related epitopes between the groups. DRB1*04, in contrast, was found among 8/8 patients with hip destruction, but also in 5/8 more benign cases. We conclude that in this type of RA patient, COMP serum levels are more informative predictors of aggressive disease than HLA DRB1* typing.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9291852     DOI: 10.1093/rheumatology/36.8.847

Source DB:  PubMed          Journal:  Br J Rheumatol        ISSN: 0263-7103


  8 in total

Review 1.  [Rheumatology update. Current knowledge of etiology, pathophysiology, diagnosis, and therapy of selected arthritic disorders. Part I: pathogenesis and differential diagnosis].

Authors:  G Hein; P Oelzner; H Sprott; B Manger
Journal:  Med Klin (Munich)       Date:  1999-09-15

2.  Early stages of osteoarthritis: the search for sensitive predictors.

Authors:  F A Wollheim
Journal:  Ann Rheum Dis       Date:  2003-11       Impact factor: 19.103

3.  Knee and/or hip joint destruction in rheumatoid arthritis is associated with HLA-DRB1*0405 in Japanese patients.

Authors:  S Wakitani; K Kuwata; K Imoto; N Murata; H Oonishi; T Ochi
Journal:  Clin Rheumatol       Date:  1998       Impact factor: 2.980

4.  Treatment strategy, disease activity, and outcome in four cohorts of patients with early rheumatoid arthritis.

Authors:  J M Albers; L Paimela; P Kurki; K B Eberhardt; P Emery; M A van 't Hof; F H Schreuder; M Leirisalo-Repo; P L van Riel
Journal:  Ann Rheum Dis       Date:  2001-05       Impact factor: 19.103

Review 5.  Cartilage oligomeric matrix protein: COMPopathies and beyond.

Authors:  Karen L Posey; Francoise Coustry; Jacqueline T Hecht
Journal:  Matrix Biol       Date:  2018-03-09       Impact factor: 11.583

6.  Cartilage oligomeric matrix protein in serum in systemic lupus erythematosus and knee osteoarthritis. Preliminary communication.

Authors:  M Wisłowska; B Jabłońska
Journal:  Rheumatol Int       Date:  2005-03-01       Impact factor: 2.631

7.  Serum cartilage oligomeric matrix protein (COMP) in rheumatoid arthritis and knee osteoarthritis.

Authors:  M Wisłowska; B Jabłońska
Journal:  Clin Rheumatol       Date:  2004-11-18       Impact factor: 2.980

8.  Cartilage Oligomeric Matrix Protein (COMP): A Biomarker of Arthritis.

Authors:  Susan Tseng; A Hari Reddi; Paul E Di Cesare
Journal:  Biomark Insights       Date:  2009-02-17
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.